APUS
Apimeds Pharmaceuticals US
APUS
APUS
8 hedge funds and large institutions have $712K invested in Apimeds Pharmaceuticals US in 2025 Q3 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
8
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$463K | |
| 2 | +$109K | |
| 3 | +$57K | |
| 4 |
Renaissance Technologies
New York
|
+$51.7K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$34.7K |
Top Sellers
| 1 | -$440K | |
| 2 | -$23.5K | |
| 3 | -$21.1K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.55K |